Prof Geltrude Mingrone MD (Chief Advisor)
Prof Geltrude Mingrone is Metadeq’s Chief Advisor and Inventor of our methods to diagnose both NASH and insulin resistance. She is credited for having discovered the causes of insulin resistance and has numerous other inventions to her name. She is Professor of Diabetes and Metabolic Disease at King’s College, and Director of the Centre for Obesity related pathologies at the Catholic University of Rome. She has pushed forward the boundaries of metabolic medicine for the last 20 years and is widely regarded as among the most recognised researchers in metabolic medicine of our time.
Prof Mingrone has published more than 300 scientific papers and written on the most prominent international journals, such as The Lancet, J Clin Invest, Diabetes, Diabetologia, Am J Physiol, etc. She regularly appears in the national and international press. She was a EU expert during the FP5and FP6. Her expertise is mainly centred on the 24h energy expenditure measurement using the Calorimetric Chamber at the Catholic University; insulin sensitivity and secretion particularly in obese/morbidly obese and diabetic subjects before and after bariatric surgery. She implemented new techniques for the clinical practice, such as BIA reconstruction of the lower limb skeletal muscle mass, referring to NMR She is actively contributing to the research aiming at elucidating the mechanisms of reversibility of diabetes after bariatric surgery.
She has been Executive Director of the European Chapter of the American College of Nutrition until 2010, Member of the Board of Directors of the American College of Nutrition, a Former Member of the Board of the European Group for the study of Insulin Resistance (EGIR), Expert in the Panel on Nutrition of the European Food Safety Authority (EFSA) until 2005, Member of the Board of the Group of Nutrition of the EASD.